Clinical trial
Effects of Raloxifene on Hormone Levels
NCT00026962 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00026962 |
|---|---|
| Title | Effects of Raloxifene on Hormone Levels |
| Official title | Assessment of the Effects of Raloxifene on Salivary Estradiol and Progesterone Levels |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Procedure |
| Interventions | measuring estradiol and progesterone levels in saliva |
| Enrollment | 60 |
| Start date | Sep 1, 1999 |
| Completion | Aug 1, 2003 |
| First posted | Nov 15, 2001 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: